Chemoinformaics analysis of Tricyclo(3.3.1.13,7)decan-1-acetamide
| Molecular Weight | 193.29 | nRot | 2 |
| Heavy Atom Molecular Weight | 174.138 | nRig | 13 |
| Exact Molecular Weight | 193.147 | nRing | 4 |
| Solubility: LogS | -3.033 | nHRing | 0 |
| Solubility: LogP | 2.059 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 34.6111 |
| nHD | 1 | BPOL | 19.3589 |
| QED | 0.717 |
| Synth | 3.722 |
| Natural Product Likeliness | 0.014 |
| NR-PPAR-gamma | 0.018 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.024 |
| Pgp-sub | 0.025 |
| HIA | 0.003 |
| CACO-2 | -4.652 |
| MDCK | 0.0000528 |
| BBB | 0.987 |
| PPB | 0.621929 |
| VDSS | 1.043 |
| FU | 0.523565 |
| CYP1A2-inh | 0.115 |
| CYP1A2-sub | 0.15 |
| CYP2c19-inh | 0.368 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.3 |
| CYP2c9-sub | 0.348 |
| CYP2d6-inh | 0.361 |
| CYP2d6-sub | 0.103 |
| CYP3a4-inh | 0.234 |
| CYP3a4-sub | 0.099 |
| CL | 8.275 |
| T12 | 0.089 |
| hERG | 0.011 |
| Ames | 0.005 |
| ROA | 0.012 |
| SkinSen | 0.028 |
| Carcinogencity | 0.779 |
| EI | 0.343 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.566055 |